APW
CRDL icon

Aurora Private Wealth’s Cardiol Therapeutics CRDL Stock Holding History

Aurora Private Wealth’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$35K Hold
21,000
– – 0.02% 167
2026
Q2 		$22K Buy
+21,000
New +$26.6K 0.01% 177

Other funds holding CRDL

Integrity Alliance
Integrity Alliance Urbandale, Iowa $3.28B AUM 15.79% 1-Year Est. Return
PVG Asset Management
PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
MGO One Seven
MGO One Seven Beachwood, Ohio $6.08B AUM 21.44% 1-Year Est. Return
Marble Harbor Investment Counsel
Marble Harbor Investment Counsel Boston, Massachusetts $1.02B AUM 15.73% 1-Year Est. Return
Boyer Financial Services
Boyer Financial Services Newport Beach, California $125M AUM 9.98% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
BWG
Boomfish Wealth Group Alpharetta, Georgia $231M AUM 21.59% 1-Year Est. Return
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Aurora Private Wealth's CRDL Position: Q3 2026 in Review

Aurora Private Wealth held its Cardiol Therapeutics (CRDL) position steady in Q3 2026 at 21,000 shares worth $35K. The position accounts for 0.02% of the portfolio, ranked #167.

Aurora Private Wealth first reported a position in CRDL in Q2 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold CRDL as of Q3 2026.

  • Aurora Private Wealth held 21,000 shares of Cardiol Therapeutics worth $35K as of Q3 2026.
  • Aurora Private Wealth left its Cardiol Therapeutics share count unchanged in Q3 2026.
  • Cardiol Therapeutics made up 0.02% of Aurora Private Wealth's portfolio in Q3 2026, its #167 holding.
  • Aurora Private Wealth first reported a position in Cardiol Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 20 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2026.

Based on Aurora Private Wealth's 13F filing for Q3 2026, filed 20 Oct 2026.